Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-64
SponsorAlbert Einstein College of Medicine
About this trial
This project will evaluate a telemedicine-delivered, Unified Protocol for Cognitive-Behavioral Therapy (UP-CBT) enhanced with continuous glucose monitor (CGM) review to target anxiety and depressive symptoms and glycemic control in adults with type 1 diabetes.
Eligibility criteria
Qualifiers
Type 1 diabetes (T1D) duration ≥ 6 months
18-64 years old
English- or Spanish-speaking
Anxiety or depressive mood disorder as per structured diagnostic interview.
Disqualifiers
Developmental or sensory disability interfering with participation
Current pregnancy
Bipolar disorders, psychotic disorders, severe eating disorders, severe substance abuse disorders, or acute suicidal risk or self-harm
Use of medications or recent medical procedures that would impact glycemic control or use of continuous glucose monitoring (CGM) over the study
Trial design
Treatments tested in this trial
- Unified protocol for cognitive behavioral therapy (UP-CBT)
- Continuous Glucose Monitoring (CGM)
Treatment groups
94 Participants
are divided into 2 treatment groupsSponsors and collaborators
Albert Einstein College of Medicine
Lead sponsor
Juvenile Diabetes Research Foundation
Collaborator
DexCom, Inc.
Collaborator
Source ClinicalTrials.gov